Tuesday, November 07, 2006 2:08:56 AM
NGNM: Volume Spike; 99% > 20-adsv, Stock +9.33%
Monday , November 06, 2006 16:10ET
This is the 1st VOLUME alert for NGNM in the past 7 calendar days.
Trading for NeoGenomics Inc (OTCBB: NGNM) has been heavier than usual in today's session. By 16:10 ET, the stock had already traded 283,600 shares via 43 trades. The cumulative volume is 98.90% above its 20-day average of 142,582. Normally the stock experiences around 23 individual trades per session.
So far, today's volume surge has caused a net rise in NGNM's stock price. At the time of this alert, the stock was trading at $1.640, up $0.140 (+9.33%).
One year ago, the Company's shares closed at $0.240. The price has gained more than 583 percent since then.
Over the last 10 trading session NGNM has traded in a range between $1.150 and $1.540 and is currently trading 6.49% above its 52-week high of $1.540 set on November 01,2006 and 1266.67% above its 52-week low of $0.120 from January 18,2006.
In the previous 3 sessions, NGNM trading has displayed a mixed trend. Closing results have been as follows:
November 03, 2006 --- closed at $1.500 up $0.040 (+2.74%) on 279,600 shares
November 02, 2006 --- closed at $1.460 down $0.040 (-2.67%) on 63,160 shares
November 01, 2006 --- closed at $1.500 up $0.080 (+5.63%) on 201,000 shares
The Company last released news on September 25, 2006:
"NeoGenomics Unveils Comprehensive Genetic Pathology Solutions (GPS) Product Offering"
NEOGENOMICS INC
NeoGenomics, Inc.'s principle operations include providing cytogenetic and molecular biology diagnostic testing services to the oncology and perinatology sectors of the healthcare industry. The Company also conducts research activities for the early diagnosis of women's diseases, such as ovarian cancer, as well as diseases in prenates and infants.
http://knobias.com/story.htm?eid=3.1.2160c501478e1b0ab77f6e9c9eb265fa6d63b1fdf3b434f7e0e91e0c3b3ea17....
Recent NEO News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/13/2024 08:08:11 PM
- Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month • Business Wire • 06/13/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:11:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:10:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:09:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:09:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:08:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:07:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:07:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:06:32 PM
- NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management • Business Wire • 05/28/2024 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:07:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 01:39:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 01:39:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 01:38:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 01:38:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 01:38:09 AM
- NeoGenomics Reports First Quarter 2024 Results • Business Wire • 04/30/2024 11:30:00 AM
- NeoGenomics Announces Senior Leadership Promotions • Business Wire • 04/18/2024 11:05:00 AM
- NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024 • Business Wire • 04/09/2024 11:00:00 AM
- NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting • Business Wire • 03/27/2024 12:30:00 PM
- NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report • Business Wire • 03/20/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:26:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 10:33:35 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM